Xianchao Lin

762 total citations
36 papers, 502 citations indexed

About

Xianchao Lin is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xianchao Lin has authored 36 papers receiving a total of 502 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 17 papers in Surgery and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xianchao Lin's work include Pancreatic and Hepatic Oncology Research (25 papers), Pancreatitis Pathology and Treatment (9 papers) and Renal cell carcinoma treatment (7 papers). Xianchao Lin is often cited by papers focused on Pancreatic and Hepatic Oncology Research (25 papers), Pancreatitis Pathology and Treatment (9 papers) and Renal cell carcinoma treatment (7 papers). Xianchao Lin collaborates with scholars based in China, United States and Canada. Xianchao Lin's co-authors include Heguang Huang, Fengchun Lu, Yu Pan, Qinglin Fei, Ping Xiong, Minggui Pan, Zheyang Zhang, Zelin Hou, Xunbin Yu and Ronggui Lin and has published in prestigious journals such as SHILAP Revista de lepidopterología, World Journal of Gastroenterology and Cell Death and Disease.

In The Last Decade

Xianchao Lin

33 papers receiving 497 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xianchao Lin China 13 294 169 168 96 93 36 502
Fengchun Lu China 12 327 1.1× 189 1.1× 145 0.9× 162 1.7× 90 1.0× 43 588
Ralf Jesenofsky Germany 12 258 0.9× 95 0.6× 105 0.6× 143 1.5× 67 0.7× 21 452
Tsung-Wei Chen Taiwan 13 265 0.9× 178 1.1× 190 1.1× 84 0.9× 64 0.7× 28 540
Mengxuan Yang China 12 241 0.8× 175 1.0× 289 1.7× 55 0.6× 156 1.7× 29 618
Shozo Hojo Japan 10 335 1.1× 269 1.6× 184 1.1× 106 1.1× 80 0.9× 23 612
Guo‐He Lin China 10 266 0.9× 103 0.6× 118 0.7× 107 1.1× 82 0.9× 37 427
Xinxin Zhu China 13 387 1.3× 242 1.4× 157 0.9× 43 0.4× 111 1.2× 19 650
Keren Jia China 11 299 1.0× 134 0.8× 124 0.7× 87 0.9× 99 1.1× 20 523
M.M. Leblond Switzerland 10 167 0.6× 233 1.4× 147 0.9× 127 1.3× 65 0.7× 16 475
Haruhisa Kitano Japan 11 213 0.7× 166 1.0× 263 1.6× 67 0.7× 87 0.9× 16 547

Countries citing papers authored by Xianchao Lin

Since Specialization
Citations

This map shows the geographic impact of Xianchao Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xianchao Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xianchao Lin more than expected).

Fields of papers citing papers by Xianchao Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xianchao Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xianchao Lin. The network helps show where Xianchao Lin may publish in the future.

Co-authorship network of co-authors of Xianchao Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Xianchao Lin. A scholar is included among the top collaborators of Xianchao Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xianchao Lin. Xianchao Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guo, Pengfei, Han Shi, Xinyu Qiu, et al.. (2025). Metabolic, transcriptomic, and proteomic adaptations in pancreatic ductal adenocarcinoma-patient derived xenograft models across serial passages. Journal of Translational Medicine. 23(1). 732–732.
2.
Luo, Xin, et al.. (2024). Whether T-tube biliary drainage is necessary after pancreaticoduodenectomy: a single-center retrospective study. BMC Surgery. 24(1). 269–269. 1 indexed citations
3.
Chen, Cong, et al.. (2024). An evidence-based model for predicting conversion to open surgery in minimally invasive distal pancreatectomy. Surgical Endoscopy. 38(11). 6423–6436. 2 indexed citations
4.
Zhou, Yuan, et al.. (2024). Drainage posterior to pancreaticojejunostomy reduces the severity of postoperative pancreatic fistula after pancreaticoduodenectomy. World Journal of Surgical Oncology. 22(1). 315–315. 2 indexed citations
5.
Shi, Wen, Xianchao Lin, Wei Luo, et al.. (2024). Metabolic difference between patient-derived xenograft model of pancreatic ductal adenocarcinoma and corresponding primary tumor. BMC Cancer. 24(1). 485–485. 4 indexed citations
7.
Lin, Ronggui, et al.. (2023). Laparoscopic transabdominal preperitoneal repair for female patients with groin hernias. BMC Women s Health. 23(1). 422–422. 6 indexed citations
8.
Luo, Xin, Xianchao Lin, Ronggui Lin, et al.. (2023). The CA125 level postoperative change rule and its prognostic significance in patients with resectable pancreatic cancer. BMC Cancer. 23(1). 832–832. 7 indexed citations
9.
Chen, Cong, Xianchao Lin, Ronggui Lin, Heguang Huang, & Fengchun Lu. (2023). A high serum creatine kinase (CK)-MB-to-total-CK ratio in patients with pancreatic cancer: a novel application of a traditional marker in predicting malignancy of pancreatic masses?. World Journal of Surgical Oncology. 21(1). 13–13. 6 indexed citations
11.
Hou, Zelin, Jiajing Lin, Zhijiang Chen, et al.. (2023). Single-cell RNA sequencing revealed subclonal heterogeneity and gene signatures of gemcitabine sensitivity in pancreatic cancer. Frontiers in Pharmacology. 14. 1193791–1193791. 13 indexed citations
12.
Lin, Ronggui, et al.. (2021). Perioperative outcomes of robotic pancreaticoduodenectomy: a single surgeon’s experience with 55 consecutive cases. Gland Surgery. 10(1). 122–129. 3 indexed citations
13.
Lin, Xianchao, et al.. (2021). Laparoscopic biopsy and staging for locally advanced pancreatic cancer: experiences of 76 consecutive patients in a single institution. Langenbeck s Archives of Surgery. 406(7). 2315–2323. 3 indexed citations
15.
Fei, Qinglin, et al.. (2020). Serum biomarker CD163 predicts overall survival in patients with pancreatic ductal adenocarcinoma. SHILAP Revista de lepidopterología. 3(3). 147–153. 1 indexed citations
17.
Hou, Zelin, Yu Pan, Qinglin Fei, et al.. (2020). Prognostic significance and therapeutic potential of the immune checkpoint VISTA in pancreatic cancer. Journal of Cancer Research and Clinical Oncology. 147(2). 517–531. 47 indexed citations
18.
Pan, Yu, Fengchun Lu, Ping Xiong, et al.. (2018). WIPF1 antagonizes the tumor suppressive effect of miR-141/200c and is associated with poor survival in patients with PDAC. Journal of Experimental & Clinical Cancer Research. 37(1). 167–167. 30 indexed citations
19.
Shi, Wen, et al.. (2017). Non-invasively predicting differentiation of pancreatic cancer through comparative serum metabonomic profiling. BMC Cancer. 17(1). 708–708. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026